8378511falsePharmaceutical services.2023-02-012024-01-31http://www.companieshouse.gov.uk/2023-01-31http://www.companieshouse.gov.uk/cd:Director12023-02-012024-01-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2023-02-012024-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-01-31http://www.companieshouse.gov.uk/2023-02-012024-01-31http://www.companieshouse.gov.uk/2023-01-31http://www.companieshouse.gov.uk/2024-01-31http://www.companieshouse.gov.uk/cd:FullAccounts2023-02-012024-01-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2023-02-012024-01-31http://www.companieshouse.gov.uk/cd:Micro-entities2023-02-012024-01-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 8378511

RAR Pharmaceutics Ltd

ACCOUNTS
FOR THE YEAR ENDED 31/01/2024

Prepared By:
Avalon Partners Ltd
35 Watling St Rd
Preston
PR2 8EA

RAR Pharmaceutics Ltd

Registered Number: 8378511
BALANCE SHEET AT 31/01/2024
20242023
££
Fixed assets453604
Current assets1,8231,685
Creditors: amounts falling due within one year-(171)
Net Current Assets1,8231,514
Total assets less current liabilities2,2762,118
Net Assets2,2762,118
Capital and reserves2,2762,118
Average Number of Employees
During the year the average number of employees was 1.
Company information
Private company limited by shares registered in EW - England and Wales, registered number 8378511. Registered office 18 Avenue Rd, Darlaston, West Midlands, WS10 8AR, UK
For the year ending 31/01/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the micro-entities regime.
These accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 28/10/2024 and signed on their behalf by
.............................
R A Ravat
Director